Caprion Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Caprion Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10466
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Caprion Biosciences Inc (Caprion) is a provider of proteomics and immune monitoring services. The company provides proteomic based services such as neo-epitope discovery and characterization, biomarker discovery, fit-for-purpose assays, host cell protein detection, PK assays, and others. It provides services such as biomarker discovery, fit for purpose assays, bioanalytical services, clinical diagnostic assays, flow cytometry, ELISpot and serological assays, among others. Caprion develops in-vitro diagnostic product candidates in the areas of infectious diseases, oncology and diabetes. The company collaborates with biotechnology and pharmaceutical companies for its research and development activities. Caprion is headquartered in Montreal, Quebec, Canada.

Caprion Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Caprion Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Caprion Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Caprion Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Caprion Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Caprion Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Caprion Biosciences Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Caprion Biosciences Acquires Immune Monitoring Lab from ImmuneHealth 10
Private Equity 11
GHO Capital Partners Acquires Caprion Biosciences from Chicago Growth Partners 11
Partnerships 12
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 12
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 13
Acquisition 15
Caprion Biosciences Acquires Primity Bio 15
Caprion Biosciences Inc – Key Competitors 16
Caprion Biosciences Inc – Key Employees 17
Caprion Biosciences Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Legal and Regulatory 19
Sep 13, 2017: Caprion Biosciences Receives College of American Pathologists Accreditation & Clinical Laboratory Improvement Amendments Certification 19
Product News 20
Jul 26, 2017: Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis Infections 20
Feb 17, 2017: Caprion Biosciences to Lead Short Course and Present Poster at Molecular Medicine Tri-Conference in San Francisco 21
Feb 15, 2017: Caprion Biosciences to Present Poster at Biologic Manufacturing Asia 22
Other Significant Developments 23
Aug 23, 2017: Caprion Biosciences and the FNIH Biomarkers Consortium Partner to Improve Monitoring of Early Alzheimer’s Disease Progression and Treatment Response 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Caprion Biosciences Inc, Medical Equipment, Key Facts 2
Caprion Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Caprion Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Caprion Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Caprion Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Caprion Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Caprion Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Caprion Biosciences Acquires Immune Monitoring Lab from ImmuneHealth 10
GHO Capital Partners Acquires Caprion Biosciences from Chicago Growth Partners 11
Caprion Enters into Licensing Agreement with Integrated Diagnostics for Xpresys Lung Test 12
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 13
Caprion Biosciences Acquires Primity Bio 15
Caprion Biosciences Inc, Key Competitors 16
Caprion Biosciences Inc, Key Employees 17
Caprion Biosciences Inc, Other Locations 18
Caprion Biosciences Inc, Subsidiaries 18

List of Figures
Caprion Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Caprion Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Caprion Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Caprion Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Caprion Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Caprion Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Caprion Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Caprion Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Caprion Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sohar Power Company SAOG:発電所・企業SWOT分析
    Sohar Power Company SAOG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Prezzo Ltd:企業の戦略・SWOT・財務情報
    Prezzo Ltd - Strategy, SWOT and Corporate Finance Report Summary Prezzo Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Virometix AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Virometix AG (Virometix) is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. The company’s pipeline products include prophylactic and therapeutic vaccines for infectious, respiratory, and onc …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Daniel Thwaites Plc:企業の戦略・SWOT・財務分析
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Graphic Packaging Holding Company
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Eurofins Scientific SE:戦略・SWOT・企業財務分析
    Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report Summary Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Avadel Pharmaceuticals Plc (AVDL):製薬・医療:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Siemens Building Technologies:企業の戦略的SWOT分析
    Siemens Building Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Elizabeth Arden, Inc. (RDEN):企業の財務・戦略的SWOT分析
    Elizabeth Arden, Inc. (RDEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Centerra Gold Inc.
    Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析
    Summary Marinus Pharmaceuticals Inc (Marinus) is a clinical stage biopharmaceutical company that manufactures and commercializes therapeutics for the treatment of epilepsy, neuropsychiatric disorders and others diseases. The company’s pipeline product comprise ganaxolone is a CNS-selective GABAA mod …
  • Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • Aqua Bio Technology ASA (ABT):企業の財務・戦略的SWOT分析
    Summary Aqua Bio Technology ASA (ABT) is a biotechnology company that develops, produces and markets new active ingredients. The company’s products comprise Aquabeautine XL and Smids. Its product Aquabeautine XL is derived from the hatching fluid of salmon. ABT’s products are based on research and d …
  • DEME NV:企業の戦略的SWOT分析
    DEME NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Compal Electronics, Inc.:戦略・SWOT・企業財務分析
    Compal Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Compal Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CompuGroup Medical Deutschland AG (COP):医療機器:M&Aディール及び事業提携情報
    Summary CompuGroup Medical Deutschland AG (CGM) is a provider of medical software products and healthcare services. The company provides products such as communication solutions, software assisted medicine, dentist information systems, ambulatory information systems, drug safety and patient marketin …
  • Opiant Pharmaceuticals Inc (OPNT):医療機器:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • VION N.V.:企業の戦略・SWOT・財務分析
    VION N.V. - Strategy, SWOT and Corporate Finance Report Summary VION N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆